While these results aligned with previous studies (e.g., Mishra et al., 2019), they highlighted the complexity of immune–melanoma interactions, suggesting that other immune or tumor-related factors may play key roles in modulating MITF expression, warranting further mechanistic investigation. This evidence concerns the gene MITF and melanoma.